Medrone (Methylprednisolone)

Methylprednisolone is a systemic glucocorticoid used to modulate inflammatory and immune pathways in various disorders.

• Rheumatoid arthritis: reduces joint inflammation and pain, improving function.
• Asthma: controls acute exacerbations and chronic inflammation of the airways.
• Allergic reactions: diminishes severe allergic responses such as angioedema and anaphylaxis.
• Dermatologic inflammatory conditions: alleviates skin inflammation in conditions like eczema and psoriasis.
• Multiple sclerosis exacerbations: shortens the duration and severity of neurologic relapses.

• Methylprednisolone binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and interacts with glucocorticoid response elements on DNA. This alters transcription of multiple genes, suppressing pro‑inflammatory cytokines (e.g., IL‑1, IL‑6, TNF‑α) and up‑regulating anti‑inflammatory proteins such as annexin‑1, thereby producing potent anti‑inflammatory and immunosuppressive effects. The overall result is decreased leukocyte migration, reduced capillary permeability, and inhibition of fibroblast proliferation.

Methylprednisolone may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Increased appetite: may lead to weight gain.
• Fluid retention: causing mild edema.
• Elevated blood glucose: especially in diabetic patients.
• Mood changes: such as irritability or insomnia.
• Gastrointestinal discomfort: including dyspepsia.

Serious or Rare Side Effects

• Severe infection: due to immunosuppression.
• Osteoporosis: with long‑term use.
• Adrenal suppression: causing cortisol deficiency.
• Psychosis or severe mood disorders.
• Thromboembolic events: rare but serious.

When prescribing methylprednisolone, clinicians should consider several precautionary measures to minimise risk.

• Assess infection risk: evaluate for active or latent infections before initiating therapy.
• Monitor glucose: check blood sugar levels in diabetic or at‑risk patients.
• Evaluate bone health: consider calcium and vitamin D supplementation for long‑term use.
• Taper dose: avoid abrupt discontinuation to prevent adrenal insufficiency.
• Review psychiatric history: monitor for mood or behavioral changes.
• Store at ambient temperature: keep tablets in the original container, protect from moisture and light.

Methylprednisolone can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

• Live vaccines: concurrent use may result in vaccine failure.
• Strong CYP3A4 inducers (e.g., rifampin): may reduce steroid levels.

Moderate Interactions (Monitor Closely)

• Anticoagulants (warfarin): may enhance anticoagulant effect.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase risk of gastrointestinal bleeding.
• Diabetic agents: may require dose adjustment due to hyperglycaemia.
• Antihypertensives: possible reduction in blood pressure control.